A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese
Status:
Completed
Trial end date:
2019-07-27
Target enrollment:
Participant gender:
Summary
The study is investigating new medicines for weight control in people with high body weight.
The study looks at how the study medicines work in the body. Participants will get
semaglutide and either NNC0165-1562 or "dummy" medicine -which treatment participants get is
decided by chance. Participants will get 2 injections per week for 5 months. A study nurse at
the clinic will inject the medicine with a thin needle in a skin fold in the stomach. The
study will last for about 7 months. Participants will have 27 visits to the clinic.